UAMS DEPARTMENT OF PATHOLOGY AND LABORATORY SERVICES
PROCESS CONTROL / VALIDATION POLICY
I.
INTRODUCTION/PRINCIPLE:
Quality Improvement standards require that each process/procedure
operates in a state of
control. This proof of operation is verified by a process
validation. Each new process/
procedure in the clinical laboratory must be validated prior to
implementation. The
existing processes may be validated with the system audits already in
existence.
II. SPECIMEN/REAGENTS/EQUIPMENT:
1. New
Process
2. Process Validation Form
3. Manufacture’s instructions
if required
III. PROCEDURE:
I. Process Validation
A. Identifying new processes that require validation.
1.
Each time the Laboratory switches from one method to another,
or a new process is introduced,
the new process has to be validated.
B. Process validation for a new method of processing.
1.
If the Laboratory is changing methods, then the new method must be
validated, and the end result compared to the end result of the old method.
2. The new method’s end result must compare favorably with the old
method’s end result. The new method must show some form of
improvement such as saving time, space, money, or providing a
superior product that will benefit the patient or the institution.
3. This comparison will be documented and reviewed by the Supervisor,
Medical and Administrative Director, Manager and Quality Assurance
Officer as necessary. All of the parties must agree on the use of
the product.
The Medical Director has the final ruling on the use of a new product
or method.
C. Process validation for a new process.
1. The new process must be validated prior to use.
2. Most manufacturers should provide us with a model of a validation
process
or recommendations.
3. Follow the manufacturer’s recommendations for validation process.
4. If
the manufacturer does not have any recommendations for validation, then
the Supervisor, Manager, Quality Assurance Officer and Medical and
Administrative Director will decide on a method of validation.
5.
The validation will be documented and reviewed
by the Supervisor, Medical
and Administrative Director, Quality Assurance Officer, and Manager.
6. The end results will be set by the Supervisor, Medical and
Administrative
Director, Quality Assurance Officer, and Manager. If the end
results are not
the results expected, then the process will not be accepted.
IV. RESULTS:
The new method or new process must benefit the laboratory
and/or patient prior to its
use. The review staff will review the validation with the
laboratory staff and UAMS
patient in mind.
V. NOTES:
The laboratory section involved will perform the validation
and the management must
review the results and agree on the use of the new method or process.
The Medical
Director always has the right to override the ruling of the review
staff if the process is
deemed a medical necessity.
VI. RECORD RETENTION:
Records of the new validation process as well as the
previously used process must
be maintained according to federal and regulatory requirements.
VII. REFERENCES:
American Association of Blood Banks, TECHNICAL MANUAL,
14th Edition, Bethesda,
MD., 2002.
American Association of Blood Banks, “STANDARDS for BLOOD BANKS and
TRANSFUSION SERVICES”, 20th Edition, Bethesda, MD
2002.
Office of the Federal Register, Code of Federal Regulations, Title 21, Washington: 2000.
VIII.
SIGNATURES:
Policy review date and signatures are available and on file in the Laboratory.
UAMS DEPARTMENT OF PATHOLOGY AND LABORATORY SERVICES
4301 WEST MARKHAM STREET
LITTLE ROCK, ARKANSAS 72205
PROCESS VALIDATION FORM
Description of Validation:
________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
Expected End Results:
__________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
Actual End Results of Validation:
____________________________________________________________________
_____________________________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
____________________________________________________________________________________________
Was the New Method / Process Validation Successful? ___ Yes ___
No
If yes; date of implementation of new method or process. _________
Supervisor Review / Date: ________________________________________________
Manager Review / Date:
________________________________________________
Medical Director Review / Date: ___________________________________________
Administrative Director Review / Date: _____________________________________
Quality Assurance Officer Review / Date: ___________________________________
Process Change Control Checklist
Department of Pathology and Laboratory Services
Laboratory Section:______________Process Change Control Number:_______________Date: ___________
| SYSTEM | DESCRIPTION | PERSON(S) RESPONSIBLE | DATE COMPLETED | COMMENTS |
| Laboratory Information System |
|
|||
| Financial Management |
|
|||
| Media Services |
|
|||
| Communication Plan |
|
|||
| Other (describe) Training Documentation |
|
Approval:
__________________________
Date:
__________________________ Date:
Section Supervisor
Clinical Manager
__________________________
Date:
___________________________ Date:
Administrative Director
Medical Director
Implementation (Go Live) Date: _____________________